SODIUM FLUORIDE F-18

SODIUM FLUORIDE F-18 was reported 1108 times

SODIUM FLUORIDE F-18 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRAIN OF CEREBRAL SUBDURAL SPACE 1 0.3333
1 VERTEBRAL LATERAL RECESS STENOSIS 6 0.3158
2 LIGAMENTUM FLAVUM HYPERTROPHY 6 0.1304
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 70 0.1048
4 IDIOPATHIC PARTIAL EPILEPSY 1 0.1000
5 OSTEOARTHROPATHY 6 0.0822
6 SERONEGATIVE ARTHRITIS 90 0.0785
7 LUPUS VULGARIS 92 0.0730
8 RESPIRATORY TRACT INFECTION BACTERIAL 26 0.0522
9 RETINITIS 88 0.0509
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 92 0.0459
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 94 0.0453
12 DISLOCATION OF VERTEBRA 99 0.0434
13 FREE FATTY ACIDS INCREASED 1 0.0303
14 HYPOAESTHESIA EYE 17 0.0288
15 SWOLLEN JOINT COUNT INCREASED 82 0.0257
16 ANDROGENS ABNORMAL 1 0.0227
17 BONE EROSION 78 0.0220
18 RHEUMATIC FEVER 90 0.0202
19 SWOLLEN JOINT COUNT 5 0.0200
20 CYTOMEGALOVIRUS SYNDROME 3 0.0182
21 GRIP STRENGTH 4 0.0175
22 ACQUIRED CYSTIC KIDNEY DISEASE 1 0.0172
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
24 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
25 WALKING AID USER 103 0.0156
26 SPONDYLITIS 56 0.0154
27 RHEUMATOID FACTOR POSITIVE 86 0.0149
28 INFECTION IN AN IMMUNOCOMPROMISED HOST 10 0.0139
29 SPINAL FUSION SURGERY 56 0.0138
30 WOUND INFECTION 150 0.0137
31 DIAPHRAGMATIC INJURY 1 0.0135
32 DUODENAL ULCER PERFORATION 90 0.0121
33 PIRIFORMIS SYNDROME 2 0.0118
34 RESPIRATORY TRACT INFECTION VIRAL 27 0.0116
35 MUSCLE INJURY 95 0.0115
36 GRIP STRENGTH DECREASED 98 0.0111
37 BREAST CANCER STAGE III 72 0.0111
38 HELICOBACTER INFECTION 114 0.0111
39 PEMPHIGUS 132 0.0105
40 AORTIC EMBOLUS 1 0.0104
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 71 0.0099
42 HYPERCHOLESTEROLAEMIA 95 0.0098
43 LUPUS-LIKE SYNDROME 89 0.0098
44 JOINT DISLOCATION 100 0.0095
45 FOLLICULITIS 98 0.0093
46 EXOSTOSIS 82 0.0090
47 C-REACTIVE PROTEIN 8 0.0086
48 BODY HEIGHT ABNORMAL 1 0.0086
49 AUTOIMMUNE DISORDER 83 0.0085
50 FIBRIN D DIMER INCREASED 30 0.0084
51 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 52 0.0080
52 PERICARDITIS 132 0.0078
53 FOOT DEFORMITY 86 0.0078
54 RED BLOOD CELL SEDIMENTATION RATE INCREASED 85 0.0077
55 TOE OPERATION 6 0.0076
56 HAND DEFORMITY 99 0.0075
57 PRESCRIBED UNDERDOSE 146 0.0073
58 JOINT RANGE OF MOTION DECREASED 98 0.0073
59 X-RAY ABNORMAL 13 0.0073
60 BURN ORAL CAVITY 4 0.0069
61 HEPATIC ENZYME 1 0.0067
62 SCIATICA 101 0.0063
63 CHOLELITHIASIS OBSTRUCTIVE 1 0.0060
64 BONE ATROPHY 1 0.0059
65 FACET JOINT SYNDROME 19 0.0058
66 AEROPHAGIA 1 0.0057
67 OVERLAP SYNDROME 4 0.0057
68 DRUG TOLERANCE DECREASED 16 0.0057
69 EYELID INJURY 1 0.0057
70 PRESCRIBED OVERDOSE 108 0.0056
71 PORPHYRIA ACUTE 8 0.0056
72 NASAL SEPTAL OPERATION 2 0.0055
73 SYNOVITIS 95 0.0053
74 FIBROMYALGIA 127 0.0052
75 HIP ARTHROPLASTY 80 0.0052
76 WOUND 146 0.0052
77 BLOOD GROWTH HORMONE DECREASED 1 0.0050
78 PULMONARY FIBROSIS 95 0.0049
79 IRRITABLE BOWEL SYNDROME 105 0.0049
80 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
81 LOWER LIMB FRACTURE 92 0.0048
82 TYPE 2 DIABETES MELLITUS 160 0.0047
83 HEPATIC CIRRHOSIS 89 0.0047
84 GLOSSODYNIA 104 0.0046
85 LIVER INJURY 113 0.0046
86 DIVORCED 2 0.0045
87 LIVER FUNCTION TEST INCREASED 92 0.0043
88 CREST SYNDROME 1 0.0042
89 PERIPHERAL VENOUS DISEASE 17 0.0042
90 GINGIVAL INJURY 1 0.0041
91 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
92 JOINT STIFFNESS 102 0.0039
93 DENTURE WEARER 1 0.0039
94 DUMPING SYNDROME 1 0.0038
95 GROWTH DISORDER 1 0.0037
96 ANTICIPATORY ANXIETY 1 0.0037
97 DISABILITY 71 0.0036
98 DENTAL PLAQUE 1 0.0036
99 BUNION OPERATION 2 0.0036
100 DAIRY INTOLERANCE 1 0.0036
101 C-REACTIVE PROTEIN INCREASED 122 0.0033
102 KNEE ARTHROPLASTY 70 0.0033
103 EPIPHYSES PREMATURE FUSION 1 0.0033
104 INFECTIVE EXACERBATION OF BRONCHIECTASIS 1 0.0033
105 OSTEOARTHRITIS 138 0.0033
106 GASTROENTERITIS ROTAVIRUS 1 0.0032
107 UPPER RESPIRATORY TRACT INFECTION 145 0.0031
108 EYE INFECTION VIRAL 1 0.0031
109 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
110 EAR INFECTION 82 0.0031
111 SYSTEMIC LUPUS ERYTHEMATOSUS 106 0.0030
112 DELIRIUM 103 0.0030
113 IMPAIRED HEALING 97 0.0030
114 DECREASED VIBRATORY SENSE 1 0.0029
115 GAIT INABILITY 98 0.0029
116 HYPOCHOLESTEROLAEMIA 1 0.0028
117 OSTEOPOROSIS 116 0.0028
118 ENDOMETRIAL ABLATION 1 0.0028
119 PSORIATIC ARTHROPATHY 113 0.0028
120 ANKLE ARTHROPLASTY 1 0.0028
121 GASTROSTOMY 4 0.0026
122 SINUS PAIN 6 0.0026
123 DEPENDENCE ON RESPIRATOR 1 0.0025
124 DISEASE RISK FACTOR 1 0.0025
125 TONSIL CANCER 2 0.0025
126 FAECES SOFT 18 0.0025
127 DRUG-INDUCED LIVER INJURY 77 0.0025
128 VERTEBRAL FORAMINAL STENOSIS 2 0.0024
129 WHEEZING 142 0.0024
130 GASTROINTESTINAL CANDIDIASIS 1 0.0024
131 BLEPHAROSPASM 15 0.0024
132 OEDEMA 129 0.0024
133 PERIORBITAL PAIN 2 0.0024
134 CYTOKINE RELEASE SYNDROME 47 0.0023
135 ROAD TRAFFIC ACCIDENT 98 0.0023
136 HOMELESS 1 0.0022
137 BANKRUPTCY 1 0.0022
138 NEUROPSYCHIATRIC SYMPTOMS 2 0.0022
139 C-REACTIVE PROTEIN ABNORMAL 14 0.0022
140 ONYCHOMADESIS 9 0.0021
141 ECZEMA ASTEATOTIC 1 0.0021
142 BLOOD CHOLESTEROL INCREASED 99 0.0021
143 ANAEMIA NEONATAL 1 0.0021
144 EXOSTOSIS OF JAW 1 0.0020
145 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
146 BLOOD DISORDER 16 0.0020
147 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
148 OROPHARYNGEAL DISCOMFORT 18 0.0020
149 LIP DRY 18 0.0020
150 BLADDER OBSTRUCTION 1 0.0019
151 ACCIDENT AT HOME 1 0.0019
152 JOINT DESTRUCTION 3 0.0019
153 ABDOMINAL INJURY 1 0.0019
154 BONE CANCER METASTATIC 1 0.0019
155 ANTIPSYCHOTIC DRUG LEVEL DECREASED 1 0.0019
156 ONYCHOMYCOSIS 8 0.0018
157 RHINALGIA 5 0.0018
158 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
159 GENITAL DISCOMFORT 1 0.0018
160 LIVE BIRTH 15 0.0018
161 BONE FRAGMENTATION 1 0.0018
162 PUSTULAR PSORIASIS 6 0.0017
163 MOBILITY DECREASED 125 0.0017
164 PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0017
165 BURSITIS 21 0.0017
166 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 83 0.0017
167 ENTERAL NUTRITION 1 0.0017
168 AORTIC CALCIFICATION 1 0.0017
169 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
170 ARTHROPATHY 92 0.0017
171 INFUSION RELATED REACTION 109 0.0016
172 FEBRILE CONVULSION 2 0.0016
173 BLOOD IRON DECREASED 19 0.0016
174 NAIL DISORDER 14 0.0016
175 HEPATOBILIARY DISEASE 1 0.0016
176 DISCOMFORT 95 0.0016
177 LIP INJURY 2 0.0015
178 GINGIVAL DISCOMFORT 1 0.0015
179 BREAST CANCER STAGE I 14 0.0015
180 STOMATITIS 90 0.0015
181 HEPATIC ENZYME INCREASED 101 0.0015
182 GAMBLING DISORDER 4 0.0015
183 MUSCULOSKELETAL STIFFNESS 129 0.0015
184 CONGENITAL HAND MALFORMATION 1 0.0015
185 AMNESIA 95 0.0015
186 TONGUE BITING 3 0.0015
187 SPINAL STENOSIS 6 0.0015
188 BREAST CANCER STAGE II 12 0.0014
189 BLISTER 81 0.0014
190 INJURY 100 0.0014
191 BORDERLINE PERSONALITY DISORDER 1 0.0014
192 ATROPHIC VULVOVAGINITIS 1 0.0014
193 GINGIVAL SWELLING 6 0.0014
194 COCCYDYNIA 2 0.0014
195 BLUNTED AFFECT 1 0.0014
196 INFUSION SITE REACTION 4 0.0013
197 MYOSITIS 12 0.0013
198 CARDIAC INFECTION 1 0.0013
199 CROUP INFECTIOUS 1 0.0013
200 SEBORRHOEIC DERMATITIS 2 0.0012
201 GASTROENTERITIS SALMONELLA 1 0.0012
202 CULTURE POSITIVE 1 0.0012
203 CYSTOCELE 1 0.0012
204 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
205 RESPIRATORY TRACT INFECTION 29 0.0011
206 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
207 SINUSITIS 112 0.0011
208 ESSENTIAL HYPERTENSION 2 0.0011
209 VISUAL IMPAIRMENT 134 0.0011
210 BRONCHITIS 80 0.0011
211 ADENOCARCINOMA GASTRIC 1 0.0011
212 SWELLING 100 0.0011
213 ARTHRITIS 84 0.0011
214 OEDEMA PERIPHERAL 130 0.0011
215 HYPERVIGILANCE 1 0.0010
216 ULCER HAEMORRHAGE 7 0.0010
217 EAR PAIN 20 0.0010
218 COELIAC DISEASE 10 0.0010
219 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
220 COLON ADENOMA 1 0.0010
221 PERIPHERAL SWELLING 155 0.0010
222 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
223 GINGIVAL PAIN 8 0.0010
224 AUTONOMIC NEUROPATHY 1 0.0010
225 TACHYCARDIA 87 0.0010
226 MUSCULAR WEAKNESS 111 0.0010
227 GENERAL PHYSICAL HEALTH DETERIORATION 113 0.0010
228 CONTUSION 94 0.0010
229 JOINT SWELLING 117 0.0010
230 BONE DEMINERALISATION 1 0.0009
231 RHEUMATOID ARTHRITIS 107 0.0009
232 OBESITY 15 0.0009
233 ASTERIXIS 1 0.0009
234 LOOSE TOOTH 3 0.0009
235 BONE NEOPLASM 1 0.0009
236 EXPOSED BONE IN JAW 2 0.0009
237 CHAPPED LIPS 4 0.0009
238 HYPOVENTILATION 3 0.0009
239 URTICARIA 153 0.0009
240 SPINAL OSTEOARTHRITIS 8 0.0009
241 SLEEP DISORDER 64 0.0009
242 PREGNANCY AFTER POST COITAL CONTRACEPTION 2 0.0009
243 IMMUNODEFICIENCY 13 0.0009
244 CHEMICAL BURN 1 0.0009
245 PRODUCT LABEL CONFUSION 5 0.0009
246 HYPORESPONSIVE TO STIMULI 1 0.0009
247 NASOPHARYNGITIS 157 0.0009
248 DYSPEPSIA 83 0.0008
249 RASH VESICULAR 4 0.0008
250 CLOSTRIDIUM COLITIS 1 0.0008
251 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
252 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
253 HAEMATOCRIT ABNORMAL 1 0.0008
254 DENTAL CARIES 9 0.0008
255 ABDOMINAL DISCOMFORT 136 0.0008
256 BLOOD UREA DECREASED 1 0.0008
257 GENERAL SYMPTOM 6 0.0008
258 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
259 HYPERAESTHESIA TEETH 1 0.0008
260 WEIGHT INCREASED 177 0.0008
261 ASTHMA 89 0.0008
262 GLUCOSE URINE PRESENT 1 0.0008
263 HEPATIC INFECTION 1 0.0008
264 HYPOAESTHESIA 116 0.0008
265 INFECTION 112 0.0008
266 RHINOVIRUS INFECTION 3 0.0008
267 ABDOMINAL OPERATION 1 0.0008
268 DRUG CLEARANCE DECREASED 1 0.0008
269 MEMORY IMPAIRMENT 105 0.0008
270 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
271 SKIN DISCOMFORT 2 0.0007
272 BACK INJURY 8 0.0007
273 CARBON DIOXIDE INCREASED 1 0.0007
274 CLUSTER HEADACHE 1 0.0007
275 HEAD TITUBATION 1 0.0007
276 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
277 CULTURE URINE POSITIVE 1 0.0007
278 PSORIASIS 92 0.0007
279 HYPERTONIC BLADDER 2 0.0007
280 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
281 TOOTH INJURY 3 0.0007
282 LUMBAR SPINAL STENOSIS 2 0.0007
283 ORAL CANDIDIASIS 9 0.0007
284 HAEMORRHAGIC ANAEMIA 3 0.0007
285 TOOTH DISCOLOURATION 2 0.0007
286 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
287 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
288 CRANIOCEREBRAL INJURY 2 0.0007
289 ASTIGMATISM 1 0.0007
290 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
291 SPINAL DISORDER 6 0.0006
292 THROAT TIGHTNESS 17 0.0006
293 ANTICHOLINERGIC SYNDROME 1 0.0006
294 HYPERSENSITIVITY 115 0.0006
295 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
296 PORTAL VEIN THROMBOSIS 2 0.0006
297 COSTOCHONDRITIS 1 0.0006
298 CONFUSIONAL STATE 99 0.0006
299 DENTAL IMPLANTATION 1 0.0006
300 BREAST ENLARGEMENT 2 0.0006
301 HYPERTENSION 129 0.0006
302 ALOPECIA 118 0.0006
303 DRUG INTOLERANCE 58 0.0006
304 BK VIRUS INFECTION 2 0.0006
305 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
306 FAILURE TO THRIVE 3 0.0006
307 BLOOD LACTIC ACID INCREASED 3 0.0006
308 GAIT DISTURBANCE 109 0.0006
309 POLYARTHRITIS 3 0.0006
310 MACULOPATHY 2 0.0006
311 APPLICATION SITE DISCOMFORT 1 0.0006
312 CHEILITIS 3 0.0006
313 WEIGHT DECREASED 154 0.0006
314 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
315 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
316 TASTE DISORDER 11 0.0005
317 GRANULOCYTE COUNT DECREASED 1 0.0005
318 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
319 BONE DENSITY ABNORMAL 2 0.0005
320 SNORING 2 0.0005
321 NIGHT SWEATS 17 0.0005
322 CARDIAC VALVE DISEASE 3 0.0005
323 CHEST PAIN 97 0.0005
324 CLAVICLE FRACTURE 2 0.0005
325 GINGIVAL RECESSION 1 0.0005
326 GINGIVAL DISORDER 2 0.0005
327 OESOPHAGEAL DISORDER 2 0.0005
328 HEPATIC MASS 1 0.0005
329 METABOLIC DISORDER 3 0.0005
330 HAEMOGLOBIN DECREASED 53 0.0005
331 CONVERSION DISORDER 1 0.0005
332 EARLY SATIETY 1 0.0005
333 GALLBLADDER INJURY 1 0.0005
334 ABDOMINAL WALL HAEMATOMA 1 0.0005
335 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
336 VIRAL INFECTION 17 0.0005
337 COLOSTOMY 1 0.0005
338 RESPIRATORY ACIDOSIS 2 0.0005
339 PYREXIA 176 0.0005
340 HYPERAEMIA 1 0.0005
341 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
342 POLYDIPSIA 2 0.0005
343 DYSPNOEA EXERTIONAL 19 0.0005
344 CANDIDIASIS 2 0.0005
345 FUNGAL SKIN INFECTION 2 0.0005
346 ADRENAL INSUFFICIENCY 6 0.0005
347 EYELID PAIN 1 0.0005
348 MUSCLE SPASTICITY 6 0.0005
349 COMPULSIVE SHOPPING 1 0.0005
350 IMPULSE-CONTROL DISORDER 1 0.0005
351 SCOLIOSIS 3 0.0005
352 ANAL PRURITUS 1 0.0005
353 PRE-EXISTING CONDITION IMPROVED 3 0.0005
354 HALLUCINATIONS, MIXED 2 0.0005
355 PAIN IN EXTREMITY 140 0.0005
356 EYE CONTUSION 1 0.0005
357 FULL BLOOD COUNT ABNORMAL 5 0.0005
358 FOETAL DISTRESS SYNDROME 1 0.0005
359 TONGUE DISCOMFORT 2 0.0005
360 ANAEMIA MACROCYTIC 1 0.0005
361 INTERVERTEBRAL DISC DISORDER 2 0.0005
362 DECREASED APPETITE 108 0.0005
363 PNEUMONIA 149 0.0005
364 EPILEPSY 14 0.0005
365 PARONYCHIA 2 0.0005
366 TOOTH FRACTURE 5 0.0005
367 PHYSICAL DISABILITY 2 0.0005
368 ANXIETY 128 0.0004
369 SKIN MASS 3 0.0004
370 CHOLESTATIC LIVER INJURY 1 0.0004
371 CALCINOSIS 1 0.0004
372 SNEEZING 10 0.0004
373 DYSPHONIA 26 0.0004
374 PRODUCT TASTE ABNORMAL 6 0.0004
375 CONDITION AGGRAVATED 134 0.0004
376 HAEMATOCRIT INCREASED 1 0.0004
377 ECCHYMOSIS 3 0.0004
378 RESPIRATORY DISORDER 13 0.0004
379 EYELID DISORDER 1 0.0004
380 NEPHROGENIC ANAEMIA 2 0.0004
381 ORAL DISCOMFORT 6 0.0004
382 BACK DISORDER 7 0.0004
383 BILIRUBIN CONJUGATED INCREASED 1 0.0004
384 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
385 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
386 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
387 DERMATITIS BULLOUS 3 0.0004
388 FINGER DEFORMITY 2 0.0004
389 DRY MOUTH 33 0.0004
390 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
391 DEPRESSION 91 0.0004
392 HYPERPARATHYROIDISM SECONDARY 1 0.0004
393 ECONOMIC PROBLEM 6 0.0004
394 DRUG TOLERANCE 2 0.0004
395 PATHOLOGICAL FRACTURE 2 0.0004
396 ANGLE CLOSURE GLAUCOMA 1 0.0004
397 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
398 RHINORRHOEA 25 0.0004
399 BASAL CELL CARCINOMA 6 0.0004
400 LIVER DISORDER 17 0.0004
401 PRODUCT RESIDUE PRESENT 2 0.0004
402 GINGIVITIS 2 0.0004
403 CHONDROPATHY 1 0.0004
404 BLOOD CREATININE INCREASED 24 0.0004
405 HYDROCEPHALUS 2 0.0004
406 IMPAIRED GASTRIC EMPTYING 5 0.0004
407 CLUMSINESS 1 0.0004
408 GINGIVAL BLEEDING 5 0.0004
409 FAECALOMA 2 0.0004
410 NONSPECIFIC REACTION 2 0.0004
411 ILL-DEFINED DISORDER 22 0.0004
412 GASTRIC ULCER HAEMORRHAGE 2 0.0004
413 VOMITING 169 0.0004
414 TREATMENT FAILURE 29 0.0003
415 HYPERTONIA 2 0.0003
416 HEART VALVE INCOMPETENCE 1 0.0003
417 THROMBOCYTOPENIA 39 0.0003
418 EXERCISE TOLERANCE DECREASED 2 0.0003
419 FIBULA FRACTURE 1 0.0003
420 ADENOVIRUS INFECTION 1 0.0003
421 HAEMOTHORAX 1 0.0003
422 BILIARY COLIC 1 0.0003
423 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
424 BRADYKINESIA 2 0.0003
425 ADVERSE EVENT 31 0.0003
426 CREPITATIONS 1 0.0003
427 BLOOD CULTURE POSITIVE 1 0.0003
428 CHEST DISCOMFORT 34 0.0003
429 BLOOD PRESSURE DECREASED 22 0.0003
430 BONE MARROW DISORDER 1 0.0003
431 EYE INJURY 1 0.0003
432 LUNG DISORDER 16 0.0003
433 PULMONARY EMBOLISM 31 0.0003
434 CHOLANGITIS 2 0.0003
435 FOREIGN BODY IN THROAT 1 0.0003
436 PRURITUS 122 0.0003
437 ABDOMINAL ADHESIONS 1 0.0003
438 BILE DUCT STONE 1 0.0003
439 HEPATITIS 8 0.0003
440 ADVERSE DRUG REACTION 28 0.0003
441 HAEMOGLOBIN ABNORMAL 2 0.0003
442 INCOHERENT 2 0.0003
443 VITAMIN D DEFICIENCY 3 0.0003
444 HAEMORRHOIDS 6 0.0003
445 PHARYNGEAL SWELLING 3 0.0003
446 DEAFNESS 8 0.0003
447 PRODUCT PREPARATION ISSUE 2 0.0003
448 TOOTH INFECTION 4 0.0003
449 PRODUCT FORMULATION ISSUE 2 0.0003
450 CORONAVIRUS INFECTION 2 0.0003
451 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
452 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
453 PREGNANCY 6 0.0003
454 CHOLECYSTITIS CHRONIC 2 0.0003
455 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
456 DIZZINESS 148 0.0003
457 ARTHRALGIA 123 0.0003
458 TOOTH ABSCESS 3 0.0003
459 SWELLING FACE 19 0.0003
460 HEPATIC FIBROSIS 1 0.0003
461 APLASIA PURE RED CELL 1 0.0003
462 BLOOD CREATININE ABNORMAL 1 0.0003
463 ENCEPHALITIS 2 0.0003
464 HAIR GROWTH ABNORMAL 2 0.0003
465 HYPERTRANSAMINASAEMIA 2 0.0003
466 PRODUCT ODOUR ABNORMAL 3 0.0003
467 MOUTH ULCERATION 6 0.0003
468 BRONCHIOLITIS 1 0.0003
469 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
470 FACIAL PARESIS 1 0.0003
471 GLOSSITIS 1 0.0003
472 DIVERTICULUM 2 0.0003
473 METASTASIS 2 0.0003
474 RASH 122 0.0003
475 DEVICE PLACEMENT ISSUE 1 0.0003
476 PAIN 171 0.0003
477 BONE LESION 1 0.0003
478 UNDERDOSE 20 0.0003
479 BLOOD PHOSPHORUS DECREASED 1 0.0003
480 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
481 MALNUTRITION 3 0.0003
482 OCULAR DISCOMFORT 3 0.0003
483 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
484 OSTEOPENIA 4 0.0003
485 PLATELET COUNT DECREASED 28 0.0003
486 SLEEP APNOEA SYNDROME 5 0.0003
487 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
488 COMMUNICATION DISORDER 1 0.0003
489 LIPASE INCREASED 2 0.0003
490 CONCUSSION 2 0.0003
491 CARDIOPULMONARY FAILURE 1 0.0003
492 FLUID RETENTION 13 0.0003
493 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
494 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
495 PNEUMOTHORAX 4 0.0003
496 MEDICATION ERROR 14 0.0003
497 RENAL CYST 2 0.0003
498 TRICUSPID VALVE INCOMPETENCE 2 0.0003
499 HYPERPHAGIA 1 0.0003
500 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
501 BLEPHARITIS 1 0.0002
502 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
503 FRUSTRATION TOLERANCE DECREASED 2 0.0002
504 HOMICIDAL IDEATION 1 0.0002
505 BODY TEMPERATURE INCREASED 5 0.0002
506 THERAPY NON-RESPONDER 11 0.0002
507 HYPOTENSION 49 0.0002
508 DEMYELINATION 1 0.0002
509 ARTHRITIS BACTERIAL 1 0.0002
510 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
511 TOOTH LOSS 5 0.0002
512 MIGRAINE 23 0.0002
513 ACCIDENTAL EXPOSURE 1 0.0002
514 HYPOKALAEMIA 11 0.0002
515 OROPHARYNGEAL PAIN 22 0.0002
516 INSOMNIA 63 0.0002
517 BUNDLE BRANCH BLOCK LEFT 1 0.0002
518 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
519 AORTIC VALVE INCOMPETENCE 1 0.0002
520 INFLAMMATION 12 0.0002
521 CARDIAC MURMUR 2 0.0002
522 HORDEOLUM 1 0.0002
523 HYSTERECTOMY 2 0.0002
524 SKIN SWELLING 2 0.0002
525 BONE CANCER 1 0.0002
526 NODULE 3 0.0002
527 MUSCULOSKELETAL PAIN 12 0.0002
528 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
529 TUMOUR LYSIS SYNDROME 2 0.0002
530 BLOOD CREATINE INCREASED 1 0.0002
531 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
532 IMPLANT SITE PAIN 1 0.0002
533 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
534 ORAL PAIN 5 0.0002
535 DIARRHOEA 144 0.0002
536 COVID-19 39 0.0002
537 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
538 FATIGUE 172 0.0002
539 BONE DISORDER 4 0.0002
540 END STAGE RENAL DISEASE 4 0.0002
541 HAEMOGLOBIN INCREASED 1 0.0002
542 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
543 NAUSEA 172 0.0002
544 EYE OPERATION 1 0.0002
545 PRODUCT DISTRIBUTION ISSUE 2 0.0002
546 APHONIA 3 0.0002
547 FLANK PAIN 2 0.0002
548 SQUAMOUS CELL CARCINOMA 2 0.0002
549 GASTROINTESTINAL DISORDER 19 0.0002
550 SEASONAL ALLERGY 3 0.0002
551 HYPOCALCAEMIA 4 0.0002
552 LIP SWELLING 7 0.0002
553 PRODUCT PRESCRIBING ERROR 5 0.0002
554 RECALLED PRODUCT ADMINISTERED 2 0.0002
555 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
556 NEUTROPENIA 28 0.0002
557 HEADACHE 129 0.0002
558 GASTROENTERITIS 3 0.0002
559 INFLAMMATORY BOWEL DISEASE 2 0.0002
560 NASAL CONGESTION 12 0.0002
561 EXPIRED DRUG ADMINISTERED 1 0.0002
562 FOOT OPERATION 1 0.0002
563 HAEMATOCRIT DECREASED 4 0.0002
564 HEPATIC ENZYME ABNORMAL 1 0.0002
565 PNEUMONIA ASPIRATION 5 0.0002
566 FLUID INTAKE REDUCED 1 0.0002
567 PRODUCT ADMINISTRATION ERROR 4 0.0002
568 CORONARY ARTERIAL STENT INSERTION 1 0.0002
569 DRY THROAT 2 0.0002
570 DRUG LEVEL DECREASED 2 0.0002
571 NEUTROPHIL COUNT INCREASED 2 0.0002
572 TEMPERATURE INTOLERANCE 2 0.0002
573 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
574 EXPOSURE DURING PREGNANCY 12 0.0002
575 ACUTE MYELOID LEUKAEMIA 3 0.0002
576 PULMONARY HYPERTENSION 4 0.0002
577 WEIGHT FLUCTUATION 2 0.0002
578 DYSPNOEA 107 0.0002
579 BREAST PAIN 2 0.0002
580 FOOD POISONING 1 0.0002
581 RECTAL HAEMORRHAGE 8 0.0002
582 ANAL ABSCESS 1 0.0002
583 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
584 SKIN LACERATION 2 0.0002
585 ASTHENOPIA 1 0.0002
586 AUTISM SPECTRUM DISORDER 1 0.0002
587 DEAFNESS UNILATERAL 1 0.0002
588 HYPERKERATOSIS 1 0.0002
589 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
590 DRUG LEVEL INCREASED 3 0.0002
591 VENTRICULAR FIBRILLATION 2 0.0002
592 HEART RATE ABNORMAL 1 0.0002
593 COLITIS ULCERATIVE 8 0.0002
594 NECK PAIN 10 0.0002
595 ANGIOPATHY 1 0.0002
596 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
597 BLOOD CALCIUM DECREASED 2 0.0002
598 CHOLECYSTITIS ACUTE 1 0.0002
599 RED BLOOD CELL COUNT DECREASED 5 0.0002
600 MYOCARDITIS 2 0.0002
601 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
602 ENTEROCOLITIS 1 0.0002
603 METASTASES TO LUNG 2 0.0002
604 ANAEMIA 33 0.0002
605 HYPERVENTILATION 1 0.0002
606 ELECTROLYTE IMBALANCE 2 0.0002
607 COUGH 48 0.0002
608 HYPERTRIGLYCERIDAEMIA 1 0.0002
609 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
610 LABORATORY TEST ABNORMAL 5 0.0002
611 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
612 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
613 GALLBLADDER DISORDER 3 0.0002
614 CARDIAC PACEMAKER INSERTION 1 0.0002
615 ABDOMINAL PAIN 39 0.0002
616 GASTROENTERITIS VIRAL 3 0.0002
617 PARAESTHESIA 26 0.0002
618 PRODUCT USE ISSUE 31 0.0002
619 INGUINAL HERNIA 1 0.0002
620 ENCEPHALOPATHY 4 0.0002
621 SPINAL OPERATION 2 0.0002
622 OSTEONECROSIS OF JAW 4 0.0002
623 HEPATIC STEATOSIS 3 0.0002
624 SWOLLEN TONGUE 5 0.0002
625 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
626 DERMATITIS ALLERGIC 2 0.0002
627 BLOOD URINE PRESENT 3 0.0002
628 HYPOTHYROIDISM 5 0.0002
629 HIP FRACTURE 5 0.0002
630 ANAPHYLACTIC SHOCK 4 0.0002
631 HERPES SIMPLEX 1 0.0002
632 CHOKING 3 0.0002
633 KIDNEY INFECTION 3 0.0002
634 MUCOSAL INFLAMMATION 4 0.0002
635 SEDATION 4 0.0002
636 ANHEDONIA 4 0.0002
637 DYSGRAPHIA 1 0.0002
638 IMMUNE SYSTEM DISORDER 2 0.0002
639 PANCREATITIS 8 0.0002
640 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
641 BLOOD PRESSURE ABNORMAL 3 0.0002
642 BRONCHIECTASIS 1 0.0001
643 COLITIS ISCHAEMIC 1 0.0001
644 FREQUENT BOWEL MOVEMENTS 4 0.0001
645 SINUS CONGESTION 2 0.0001
646 INFARCTION 1 0.0001
647 CROHN'S DISEASE 1 0.0001
648 CORONARY ARTERY OCCLUSION 2 0.0001
649 ABDOMINAL PAIN UPPER 30 0.0001
650 DEFAECATION URGENCY 1 0.0001
651 HYPOXIA 5 0.0001
652 HAND FRACTURE 1 0.0001
653 BRONCHOSPASM 2 0.0001
654 LEUKOPENIA 7 0.0001
655 SUBDURAL HAEMATOMA 2 0.0001
656 CRYING 5 0.0001
657 APATHY 2 0.0001
658 DYSSTASIA 4 0.0001
659 MUSCLE SPASMS 25 0.0001
660 PANCREATITIS ACUTE 3 0.0001
661 THERAPEUTIC RESPONSE DECREASED 8 0.0001
662 BLOOD COUNT ABNORMAL 2 0.0001
663 HEPATOCELLULAR CARCINOMA 1 0.0001
664 DIABETES MELLITUS 10 0.0001
665 FOOD ALLERGY 1 0.0001
666 HAEMOLYSIS 1 0.0001
667 CONGENITAL ANOMALY 1 0.0001
668 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
669 EJECTION FRACTION DECREASED 2 0.0001
670 TREATMENT NONCOMPLIANCE 7 0.0001
671 BONE DENSITY DECREASED 4 0.0001
672 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
673 DRUG SCREEN POSITIVE 1 0.0001
674 RESPIRATORY TRACT CONGESTION 2 0.0001
675 METASTASES TO BONE 2 0.0001
676 AGEUSIA 3 0.0001
677 HEMIPLEGIA 1 0.0001
678 DRY EYE 6 0.0001
679 EOSINOPHIL COUNT INCREASED 1 0.0001
680 SURGERY 7 0.0001
681 OFF LABEL USE 104 0.0001
682 INFUSION SITE ERYTHEMA 1 0.0001
683 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
684 HYPOPHAGIA 3 0.0001
685 URINARY TRACT INFECTION 20 0.0001
686 HAEMATURIA 4 0.0001
687 DYSPHAGIA 11 0.0001
688 BLOOD MAGNESIUM DECREASED 1 0.0001
689 NIGHTMARE 4 0.0001
690 SPEECH DISORDER 6 0.0001
691 NEUROTOXICITY 2 0.0001
692 BURNING SENSATION 8 0.0001
693 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
694 METASTASES TO LIVER 2 0.0001
695 DEHYDRATION 15 0.0001
696 GOUT 2 0.0001
697 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
698 ANAL INCONTINENCE 1 0.0001
699 HEAVY MENSTRUAL BLEEDING 1 0.0001
700 TOOTHACHE 2 0.0001
701 OSTEOMYELITIS 2 0.0001
702 PNEUMONITIS 3 0.0001
703 CONSTIPATION 24 0.0001
704 PANIC ATTACK 4 0.0001
705 RESTLESSNESS 4 0.0001
706 INCREASED TENDENCY TO BRUISE 1 0.0001
707 GRAND MAL CONVULSION 1 0.0001
708 HAEMOPTYSIS 3 0.0001
709 PANCYTOPENIA 6 0.0001
710 DIARRHOEA HAEMORRHAGIC 1 0.0001
711 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
712 HYPONATRAEMIA 6 0.0001
713 EYE PAIN 6 0.0001
714 PHOTOPHOBIA 2 0.0001
715 ARTERIOSCLEROSIS 1 0.0001
716 HOT FLUSH 8 0.0001
717 INTESTINAL OBSTRUCTION 4 0.0001
718 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
719 INCREASED APPETITE 2 0.0001
720 EYE IRRITATION 6 0.0001
721 POST PROCEDURAL COMPLICATION 2 0.0001
722 HOSPITALISATION 16 0.0001
723 SEIZURE 12 0.0001
724 HEPATOMEGALY 1 0.0001
725 BODY TEMPERATURE DECREASED 1 0.0001
726 HOSPICE CARE 1 0.0001
727 DISORIENTATION 4 0.0001
728 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
729 HEPATIC FAILURE 3 0.0001
730 PLEURAL EFFUSION 6 0.0001
731 ACUTE KIDNEY INJURY 15 0.0001
732 EUPHORIC MOOD 1 0.0001
733 INITIAL INSOMNIA 1 0.0001
734 EAR DISCOMFORT 1 0.0001
735 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
736 RIB FRACTURE 2 0.0001
737 LIMB DISCOMFORT 3 0.0001
738 HYPERBILIRUBINAEMIA 1 0.0001
739 RESPIRATORY FAILURE 7 0.0001
740 ECZEMA 5 0.0001
741 HALLUCINATION, VISUAL 2 0.0001
742 NEUROPATHY PERIPHERAL 9 0.0001
743 MOOD SWINGS 3 0.0001
744 EATING DISORDER 2 0.0001
745 RETCHING 2 0.0001
746 HEREDITARY ANGIOEDEMA 1 0.0001
747 DECREASED ACTIVITY 1 0.0001
748 UNEVALUABLE EVENT 7 0.0001
749 DEEP VEIN THROMBOSIS 6 0.0001
750 RASH PRURITIC 5 0.0001
751 CHRONIC KIDNEY DISEASE 7 0.0001
752 BIPOLAR DISORDER 1 0.0001
753 SEPTIC SHOCK 4 0.0001
754 CHOLELITHIASIS 3 0.0001
755 OSTEONECROSIS 3 0.0001
756 ASPIRATION 1 0.0001
757 STAPHYLOCOCCAL INFECTION 3 0.0001
758 GASTROINTESTINAL PAIN 1 0.0001
759 BACK PAIN 21 0.0001
760 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
761 TOOTH DISORDER 2 0.0001
762 RASH PAPULAR 2 0.0001
763 FISTULA 1 0.0001
764 EYE INFECTION 1 0.0001
765 HEART RATE IRREGULAR 2 0.0001
766 FLATULENCE 5 0.0001
767 IMPAIRED DRIVING ABILITY 1 0.0001
768 DERMATITIS CONTACT 1 0.0001
769 CHOLECYSTECTOMY 1 0.0001
770 NEPHROLITHIASIS 4 0.0001
771 INJECTION SITE REACTION 6 0.0001
772 PERICARDIAL EFFUSION 2 0.0001
773 ABDOMINAL DISTENSION 9 0.0001
774 CAESAREAN SECTION 1 0.0001
775 LYMPHADENOPATHY 3 0.0001
776 MALAISE 37 0.0001
777 ATAXIA 1 0.0001
778 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
779 ACCIDENT 1 0.0001
780 RASH ERYTHEMATOUS 4 0.0001
781 MULTIPLE SCLEROSIS 4 0.0001
782 IRRITABILITY 5 0.0001
783 RENAL FAILURE 11 0.0001
784 HEPATITIS C 1 0.0001
785 SUICIDE ATTEMPT 5 0.0001
786 ATRIAL FIBRILLATION 8 0.0001
787 VERTIGO 5 0.0001
788 CYTOPENIA 1 0.0001
789 FEELING HOT 5 0.0001
790 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
791 PRODUCT QUALITY ISSUE 11 0.0001
792 GENERALISED OEDEMA 1 0.0001
793 ILEUS 1 0.0001
794 HALLUCINATION 6 0.0001
795 CELLULITIS 4 0.0001
796 BRAIN OEDEMA 1 0.0001
797 COLITIS 3 0.0001
798 ERECTILE DYSFUNCTION 2 0.0001
799 ILLNESS 8 0.0001
800 SKIN ULCER 2 0.0001
801 HIATUS HERNIA 1 0.0001
802 RASH GENERALISED 2 0.0001
803 ASTHENIA 29 0.0001
804 DIPLOPIA 2 0.0001
805 DYSMENORRHOEA 1 0.0001
806 FEBRILE NEUTROPENIA 5 0.0001
807 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
808 FALL 25 0.0001
809 DYSKINESIA 3 0.0001
810 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
811 CARDIAC ARREST 6 0.0001
812 HAEMATOCHEZIA 4 0.0001
813 ABNORMAL DREAMS 2 0.0001
814 TREMOR 12 0.0001
815 MENTAL STATUS CHANGES 2 0.0001
816 HYPOMAGNESAEMIA 1 0.0001
817 HUNGER 1 0.0001
818 INFLUENZA 8 0.0001
819 DEVICE OCCLUSION 1 0.0001
820 HYPERSOMNIA 2 0.0001
821 CARDIOGENIC SHOCK 1 0.0001
822 SOMNOLENCE 14 0.0001
823 BALANCE DISORDER 6 0.0001
824 HYPERTHYROIDISM 1 0.0001
825 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
826 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
827 CARDIOMYOPATHY 1 0.0001
828 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
829 CATARACT 4 0.0001
830 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
831 EPISTAXIS 5 0.0001
832 HYPOAESTHESIA ORAL 1 0.0001
833 APHASIA 2 0.0001
834 LACRIMATION INCREASED 2 0.0001
835 VISION BLURRED 9 0.0001
836 SUICIDAL IDEATION 6 0.0001
837 DRUG DISPENSING ERROR 1 0.0001
838 INSURANCE ISSUE 1 0.0001
839 TINNITUS 3 0.0001
840 DEVICE RELATED INFECTION 1 0.0001
841 PRODUCT DOSE OMISSION ISSUE 19 0.0001
842 FEMUR FRACTURE 2 0.0001
843 DELUSION 1 0.0001
844 NERVOUS SYSTEM DISORDER 2 0.0001
845 BRAIN FOG 1 0.0001
846 ARRHYTHMIA 3 0.0001
847 HEAD INJURY 2 0.0001
848 HALLUCINATION, AUDITORY 1 0.0001
849 INJECTION SITE BRUISING 5 0.0001
850 DRUG INEFFECTIVE 82 0.0001
851 EYE DISORDER 2 0.0001
852 VISUAL ACUITY REDUCED 2 0.0001
853 CYTOMEGALOVIRUS INFECTION 1 0.0001
854 FUNGAL INFECTION 2 0.0001
855 COMPLETED SUICIDE 5 0.0001
856 RENAL IMPAIRMENT 5 0.0001
857 HEMIPARESIS 1 0.0001
858 BLOOD PRESSURE INCREASED 9 0.0001
859 DEVICE DEFECTIVE 1 0.0001
860 NEOPLASM PROGRESSION 2 0.0001
861 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
862 HAEMORRHAGE 6 0.0001
863 RASH MACULAR 2 0.0001
864 DEVICE USE ISSUE 1 0.0001
865 INTENTIONAL PRODUCT MISUSE 5 0.0001
866 DEPRESSED MOOD 3 0.0001
867 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
868 HEAD DISCOMFORT 1 0.0001
869 CEREBRAL HAEMORRHAGE 2 0.0001
870 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
871 ACCIDENTAL OVERDOSE 2 0.0001
872 INJECTION SITE MASS 2 0.0001
873 CONJUNCTIVITIS 1 0.0001
874 DYSGEUSIA 4 0.0001
875 BACTERIAL INFECTION 1 0.0001
876 DYSARTHRIA 2 0.0001
877 BLOOD SODIUM DECREASED 1 0.0001
878 FRACTURE 1 0.0001
879 FOOT FRACTURE 1 0.0001
880 GASTRIC ULCER 1 0.0001
881 CONVULSION 3 0.0001
882 DEATH 45 0.0001
883 ACUTE RESPIRATORY FAILURE 1 0.0001
884 HERNIA 1 0.0001
885 DYSTONIA 1 0.0001
886 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
887 BONE PAIN 3 0.0001
888 OVERDOSE 11 0.0001
889 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
890 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
891 ABNORMAL BEHAVIOUR 2 0.0001
892 COMPLICATION OF DEVICE INSERTION 1 0.0001
893 SYNCOPE 5 0.0000
894 THROMBOSIS 4 0.0000
895 EMOTIONAL DISTRESS 6 0.0000
896 DEVICE BREAKAGE 2 0.0000
897 BONE MARROW FAILURE 1 0.0000
898 CARDIO-RESPIRATORY ARREST 2 0.0000
899 INTENTIONAL DRUG MISUSE 1 0.0000
900 DERMATITIS 1 0.0000
901 LOSS OF CONSCIOUSNESS 6 0.0000
902 HYPOACUSIS 2 0.0000
903 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
904 DRY SKIN 6 0.0000
905 NEOPLASM MALIGNANT 3 0.0000
906 HEPATOTOXICITY 1 0.0000
907 SEPSIS 5 0.0000
908 PULMONARY OEDEMA 2 0.0000
909 SKIN IRRITATION 2 0.0000
910 RENAL DISORDER 2 0.0000
911 PALPITATIONS 5 0.0000
912 OCULAR HYPERAEMIA 2 0.0000
913 PRODUCTIVE COUGH 2 0.0000
914 BLOOD GLUCOSE DECREASED 2 0.0000
915 CEREBRAL INFARCTION 1 0.0000
916 AGITATION 3 0.0000
917 INJECTION SITE URTICARIA 1 0.0000
918 EXTRAPYRAMIDAL DISORDER 1 0.0000
919 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
920 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
921 ABDOMINAL PAIN LOWER 1 0.0000
922 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
923 GASTRIC CANCER 1 0.0000
924 NO ADVERSE EVENT 7 0.0000
925 HAEMATOMA 1 0.0000
926 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
927 DERMATITIS ATOPIC 2 0.0000
928 CARDIAC FAILURE CONGESTIVE 3 0.0000
929 BLOOD BILIRUBIN INCREASED 1 0.0000
930 ANAPHYLACTIC REACTION 2 0.0000
931 FEELING COLD 1 0.0000
932 DEMENTIA 1 0.0000
933 TOXICITY TO VARIOUS AGENTS 6 0.0000
934 SKIN EXFOLIATION 3 0.0000
935 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
936 CEREBROVASCULAR ACCIDENT 6 0.0000
937 INTENTIONAL DOSE OMISSION 1 0.0000
938 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
939 CHILLS 4 0.0000
940 ERYTHEMA 7 0.0000
941 ASCITES 1 0.0000
942 BLOOD POTASSIUM DECREASED 1 0.0000
943 INJECTION SITE RASH 1 0.0000
944 INTENTIONAL OVERDOSE 2 0.0000
945 HYPERHIDROSIS 4 0.0000
946 PRODUCT DOSE OMISSION 2 0.0000
947 EXPIRED PRODUCT ADMINISTERED 1 0.0000
948 INJECTION SITE PRURITUS 2 0.0000
949 EYE PRURITUS 1 0.0000
950 ANGER 1 0.0000
951 MYALGIA 5 0.0000
952 GASTRIC DISORDER 1 0.0000
953 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
954 HYPERKALAEMIA 1 0.0000
955 THERAPY INTERRUPTED 2 0.0000
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
957 HYPERGLYCAEMIA 1 0.0000
958 DYSURIA 1 0.0000
959 ACNE 2 0.0000
960 INJECTION SITE SWELLING 2 0.0000
961 DRUG DOSE OMISSION BY DEVICE 2 0.0000
962 DISEASE PROGRESSION 3 0.0000
963 FEELING ABNORMAL 6 0.0000
964 ABORTION SPONTANEOUS 1 0.0000
965 EXTRA DOSE ADMINISTERED 1 0.0000
966 BLINDNESS 1 0.0000
967 INFLUENZA LIKE ILLNESS 2 0.0000
968 DEVICE LEAKAGE 1 0.0000
969 DEVICE DISLOCATION 1 0.0000
970 MYOCARDIAL INFARCTION 4 0.0000
971 ANGIOEDEMA 1 0.0000
972 DEVICE ISSUE 2 0.0000
973 BREAST CANCER 2 0.0000
974 COGNITIVE DISORDER 1 0.0000
975 FLUSHING 2 0.0000
976 INJECTION SITE PAIN 6 0.0000
977 BRADYCARDIA 1 0.0000
978 DRUG DEPENDENCE 3 0.0000
979 DISTURBANCE IN ATTENTION 1 0.0000
980 HERPES ZOSTER 1 0.0000
981 INJECTION SITE ERYTHEMA 2 0.0000
982 BLOOD GLUCOSE INCREASED 3 0.0000
983 DEVICE EXPULSION 1 0.0000
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
985 INCORRECT DOSE ADMINISTERED 3 0.0000
986 DRUG INTERACTION 2 0.0000
987 CARDIAC FAILURE 1 0.0000
988 DRUG DOSE OMISSION 2 0.0000
989 DRUG WITHDRAWAL SYNDROME 1 0.0000
990 CARDIAC DISORDER 1 0.0000
991 HEART RATE INCREASED 1 0.0000